Skip to content
Open access

The circulating metatranscriptome in acute myeloid leukemia patients: an RNA-seq reanalysis

Sep 2026 · Frontiers in microbiomes · Vol 5 · 0 citations · 44 references
Medicine

TL;DR

The circulating metatranscriptome of 411 patients with acute myeloid leukemia is characterized and it is found that the circulating metatranscriptome in AML differs substantially from that of healthy controls, and high metatranscriptome loads are associated with antibacterial host response.

Abstract

The human microbiome comprises the collection of microbiota residing on or within human tissues. It is now well-established that microbial composition impacts an individual’s health. In the cancer realm, the vast majority of microbiome studies have been focused either on the gut, or at the site of solid tumors. Few studies have assessed microbial content at the site of hematological malignancies – blood and bone marrow. Here we characterize the circulating metatranscriptome (i.e. the bacterial and viral RNA in circulation) of 411 patients with acute myeloid leukemia (AML). We find that the circulating metatranscriptome in AML differs substantially from that of healthy controls, and high metatranscriptome loads are associated with antibacterial host response. We observe that specific bacterial genera are associated with response to anti-cancer therapy and disease history, and are tied to host gene expression signatures of heme metabolism. Overall, our study represents an inferred landscape of circulating microbial RNA in AML and suggests potential for its use as a biomarker.

Read PDF

Similar papers

Open access Oct 2026

Bacteria inside kidney tumors associate with myeloid inflammation and disease progression: A TRACERx Renal study.

BACKGROUND Intratumoral bacteria are increasingly recognized as active contributors to neutrophil-driven inflammation and disease progression in solid tumors. Yet, in clear cell renal cell carcinoma (ccRCC), where myeloid inflammation is a key feature of aggressive disease, live bacterial presence, their intratumoral d...

Alice C. Martin, A. Cattin, Parise K. Lockwood et al. · 0 citations
Open access Oct 2026

Recovering anaerobic bacterial genomes in saliva, tumour and blood whole genome sequencing data from patients with prostate cancer

Microbial constituents in the gastrointestinal tract, the urine and prostate tissue are being linked with clinical differences in prostate cancer, and a recent meta-analysis has linked periodontal disease to this cancer. Several hypotheses exist regarding how specific bacteria can contribute towards the development of...

A. Gihawi, A. Bampalis, Шиамсундар Субраманиан et al. · 0 citations
Open access Oct 2026

Influence of gut microbiota on chronic lymphocytic leukemia development and aggressiveness

ABSTRACT Chronic lymphocytic leukemia (CLL) is highly heterogeneous both clinically and biologically. Although genetic factors have been identified, several lines of evidence suggest a role for environmental factors in disease onset and progression. Diet is a recognized risk factor for various diseases, including cance...

M. Frenquelli, D. Farinello, Sofia Sisti et al. · 0 citations
Review Open access Oct 2026

Genome mining of the tumor microbiome reveals biosynthetic diversity and potential pathology-modulating metabolites

Human tumor-associated microbes – the tumor microbiome – have demonstrated an increasingly important role in human health due to their relevance to cancer progression and treatment response. While the metabolism at the host-microbiota interface, such as in the human gut, has been extensively investigated in recent year...

Conor Pulliam, Ming-Ming Xu, Katherine S. Holandez-Lopez et al. · 0 citations
Open access Sep 2026

Gut microbiota modulates Hyodeoxycholic Acid to Inhibit Leukemia Development.

To explore the role of gut microbiota and bile acid metabolism in Acute myeloid leukemia (AML), we analyzed samples from 29 patients via 16S rDNA sequencing and LC-QTOF-MS, and performed functional studies on Enterococcus faecalis and hyodeoxycholic acid (HDCA). Results revealed a dynamic shift in gut microbiota divers...

Jian-Da Hu, Wan-Ying Liu, Jia-Jie Yang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.